ERKI-2 and p38 MAPK regulate MMP/TIMP balance and function in response to thrombospondin-1 fragments in the microvascular endothelium

被引:47
作者
Donnini, S
Morbidelli, L
Taraboletti, G
Ziche, M
机构
[1] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy
[2] Mario Negri Inst Pharmacol Res, Dept Oncol, I-24100 Bergamo, Italy
关键词
angiogenesis; endothelium; ERK1-2; metalloproteinases;
D O I
10.1016/j.lfs.2003.09.075
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We found that thrombospondin-1 (TSP-1) has opposite functions on angiogenesis depending on the nature of the proteolytic fragment released in vivo by the action of proteases. We studied the effect of the 25 and 140 kDa fragments of TSP-1 generated by its proteolytic cleavage on the cascade of mitogen activated protein kinase (MAPK) activation and matrix-metalloproteinase (MMP)/tissue inhibitor of metalloproteinase (TIMP) function and expression in microvascular endothelium. Post-capillary endothelial cells (CVEC) isolated from bovine heart were used. The 25 kDa fragment enhanced the upregulation of MMP-2 and -9 and reduced TIMP-2 expression leading to CVEC chemoinvasion. Conversely, the 140 kDa fragment blocked MMP-2 and -9 stimulation and doubled TIMP-2 expression, leading to inhibition of endothelial chemoinvasion induced by fibroblast growth factor-2 (FGF-2). MAPK activity (ERK1-2) was induced by TSP-1 and by the 25 kDa fragment, but not by the 140 kDa fragment which, however, promoted MAPK p38 activation. This evidence indicates that fragments originating from TSP-1 switch the pro- or anti-angiogenic phenotype in endothelium by targeting MAPK cascades with opposite functions on MMP/TIMP balance. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:2975 / 2985
页数:11
相关论文
共 33 条
[1]  
Bertin N, 1997, CANCER RES, V57, P396
[2]   DIVERSITY OF FUNCTION IS INHERENT IN MATRICELLULAR PROTEINS - AN APPRAISAL OF THROMBOSPONDIN-1 [J].
BORNSTEIN, P .
JOURNAL OF CELL BIOLOGY, 1995, 130 (03) :503-506
[3]   How tumors become angiogenic [J].
Bouck, N ;
Stellmach, V ;
Hsu, SC .
ADVANCES IN CANCER RESEARCH, VOL 69, 1996, 69 :135-174
[4]  
BOULTON TG, 1991, CELL, V65, P666
[5]   Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery [J].
Chen, DH ;
Asahara, T ;
Krasinski, K ;
Witzenbichler, B ;
Yang, JH ;
Magner, M ;
Kearney, M ;
Frazier, WA ;
Isner, JM ;
Andrés, V .
CIRCULATION, 1999, 100 (08) :849-854
[6]  
CLEZARDIN P, 1993, CANCER RES, V53, P1421
[7]   CHARACTERIZATION OF THE PROMOTER OF THE GENE ENCODING HUMAN TISSUE INHIBITOR OF METALLOPROTEINASES-2 (TIMP-2) [J].
DECLERCK, YA ;
DARVILLE, MI ;
EECKHOUT, Y ;
ROUSSEAU, GG .
GENE, 1994, 139 (02) :185-191
[8]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[9]   Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent [J].
Gahtan, V ;
Wang, XJ ;
Willis, AI ;
Tuszynski, GP ;
Sumpio, BE .
SURGERY, 1999, 126 (02) :203-207
[10]   Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression [J].
Grossfeld, GD ;
Ginsberg, DA ;
Stein, JP ;
Bochner, BH ;
Esrig, D ;
Groshen, S ;
Dunn, M ;
Nichols, PW ;
Taylor, CR ;
Skinner, DG ;
Cote, RJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (03) :219-227